1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Nanexa AB (publ)

Nanexa AB (publ)

NANEXA.ST
Nanexa AB (publ)SE flagStockholm Stock Exchange
3.61
SEK
+0.06
- -
594.15MMarket Cap

Total Valuation

Nanexa AB (publ) carries a market capitalization of 594.15M, placing it among publicly traded companies globally. Its enterprise value stands at 540.82M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap594.15M
Enterprise Value540.82M

Share Statistics

Nanexa AB (publ) currently has 184.79M shares outstanding.

Shares Outstanding184.79M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 17.56, and the price-to-book ratio stands at -1.84.

PE RatioN/A
PS Ratio17.56
PB Ratio-1.84
P/TBV Ratio12.30
P/FCF Ratio27.60
P/OCF Ratio2,676.23

Enterprise Valuation

EV / Sales15.49
EV / EBITDAN/A
EV / EBITN/A
EV / FCF19.74

Financial Position

Nanexa AB (publ) maintains a current ratio of 2.06, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.78, indicating moderate leverage, while an interest coverage ratio of -4.85 demonstrates limited ability to service its debt obligations.

Current Ratio2.06
Quick Ratio1.89
Debt / Equity0.78
Debt / EBITDA-0.07
Interest Coverage-4.85

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-10.99
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover-565.30

Taxes

Income Tax-108,000.00
Effective Tax RateN/A

Stock Price Statistics

Nanexa AB (publ)'s stock has gained approximately 56.27706% over the past 52 weeks. The 50-day moving average sits at 3.86, while the 200-day moving average is 3.27.

Beta (5Y)N/A
52-Week Price Change56.27706%
50-Day Moving Average3.86
200-Day Moving Average3.27
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Nanexa AB (publ) generated 34.90M in revenue and converted that into -16.42M in net income, yielding earnings per share of -0.09. EBITDA reached -14.17M, while operating income came in at -14.17M.

Revenue34.90M
Gross Profit54.41M
Operating Income-14.17M
Pretax Income-16.53M
Net Income-16.42M
EBITDA-14.17M
EBIT-14.17M
Earnings Per Share (EPS)-0.09

Balance Sheet

Nanexa AB (publ) holds 73.02M in cash and equivalents against 987,000.00 in total debt, resulting in a net debt position of -5.34M. Total book value stands at -333.56M, with working capital of 41.09M providing operational flexibility.

Cash & Cash Equivalents73.02M
Total Debt987,000.00
Net Debt-5.34M
Equity (Book Value)-333.56M
Book Value Per Share-2.06
Working Capital41.09M

Cash Flow

Nanexa AB (publ) produced 229,000.00 in operating cash flow over the past twelve months. After subtracting -24.27M in capital expenditures, free cash flow totaled -24.04M - equivalent to -0.15 per share.

Operating Cash Flow229,000.00
Capital Expenditures-24.27M
Free Cash Flow-24.04M
FCF Per Share-0.15

Margins

Nanexa AB (publ) operates with a gross margin of 155.88, reflecting its pricing power and cost economics. The operating margin of -40.59 and net profit margin of -47.05 provide insight into operational efficiency.

Gross Margin155.88
Operating Margin-40.59
Pretax Margin-47.36
Profit Margin-47.05
EBITDA Margin-40.59

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-7.81
FCF Yield3.62

Stock Splits

Nanexa AB (publ)'s most recent stock split took place on June 11, 2021 with a 500:537 split ratio.

Last Split Date6/11/2021
Split Ratio500:537

Scores

Nanexa AB (publ) posts an Altman Z-Score of 4.12, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.12